| Report Title | Price | Action |
|---|---|---|
| Biliary Tumor (Oncology) - Drugs in Development, 2021
Biliary Tumor (Oncology) - Drugs in Development, 2021 Summary Biliary Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the Bili...
Published: Apr-2021 | No. of Pages: 45
|
$ 2000 | |
| Liver Cancer (Oncology) - Drugs in Development, 2021
Liver Cancer (Oncology) - Drugs in Development, 2021 Summary Liver Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Liver ...
Published: Apr-2021 | No. of Pages: 325
|
$ 2500 | |
| Neisseria Gonorrhoeae Infections (Infectious Disease) - Drugs in Development, 2021
Neisseria Gonorrhoeae Infections (Infectious Disease) - Drugs in Development, 2021 Summary Neisseria Gonorrhoeae Infections (Infectious Disease) - D...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Allergic Rhino-Conjunctivitis (Ophthalmology) - Drugs in Development, 2021
Allergic Rhino-Conjunctivitis (Ophthalmology) - Drugs in Development, 2021 Summary Allergic Rhino-Conjunctivitis (Ophthalmology) - Drugs in Developm...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
| Cells Expressing Hepatocyte Growth Factor Receptor (Proto Oncogene c Met or Tyrosine Protein Kinase Met or HGF/SF Receptor or Scatter Factor Receptor or MET or EC 2.7.10.1) - Drugs in Development, 2021
Cells Expressing Hepatocyte Growth Factor Receptor (Proto Oncogene c Met or Tyrosine Protein Kinase Met or HGF/SF Receptor or Scatter Factor Receptor ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Guanine Nucleotide Exchange C9orf72 (C9orf72) - Drugs in Development, 2021
Guanine Nucleotide Exchange C9orf72 (C9orf72) - Drugs in Development, 2021 Summary Guanine Nucleotide Exchange C9orf72 (C9orf72) - Drugs in Developm...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Arachidonate 15 Lipoxygenase (12/15 Lipoxygenase or Arachidonate 12 Lipoxygenase Leukocyte Type or Arachidonate Omega 6 Lipoxygenase or ALOX15 or EC 1.13.11.33 or EC 1.13.11.31) - Drugs in Development, 2021
Arachidonate 15 Lipoxygenase (12/15 Lipoxygenase or Arachidonate 12 Lipoxygenase Leukocyte Type or Arachidonate Omega 6 Lipoxygenase or ALOX15 or EC 1...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Splenic Marginal Zone B-Cell Lymphoma (Oncology) - Drugs in Development, 2021
Splenic Marginal Zone B-Cell Lymphoma (Oncology) - Drugs in Development, 2021 Summary Splenic Marginal Zone B-Cell Lymphoma (Oncology) - Drugs in De...
Published: Apr-2021 | No. of Pages: 45
|
$ 2000 | |
| Staphylococcus Aureus Infections (Infectious Disease) - Drugs in Development, 2021
Staphylococcus Aureus Infections (Infectious Disease) - Drugs in Development, 2021 Summary Staphylococcus Aureus Infections (Infectious Disease) - D...
Published: Apr-2021 | No. of Pages: 140
|
$ 2000 | |
| Nerve Injury (Central Nervous System) - Drugs in Development, 2021
Nerve Injury (Central Nervous System) - Drugs in Development, 2021 Summary Nerve Injury (Central Nervous System) - Drugs in Development, 2021 provid...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Anaplastic Large Cell Lymphoma (ALCL) (Oncology) - Drugs in Development, 2021
Anaplastic Large Cell Lymphoma (ALCL) (Oncology) - Drugs in Development, 2021 Summary Anaplastic Large Cell Lymphoma (ALCL) (Oncology) - Drugs in De...
Published: Apr-2021 | No. of Pages: 115
|
$ 2000 | |
| Cells Expressing Mucin 16 (Ovarian Cancer Related Tumor Marker CA125 or Ovarian Carcinoma Antigen CA125 or MUC16) - Drugs in Development, 2021
Cells Expressing Mucin 16 (Ovarian Cancer Related Tumor Marker CA125 or Ovarian Carcinoma Antigen CA125 or MUC16) - Drugs in Development, 2021 Summar...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Inducible T Cell Costimulator (Activation Inducible Lymphocyte Immunomediatory Molecule or CD278 or ICOS) - Drugs in Development, 2021
Inducible T Cell Costimulator (Activation Inducible Lymphocyte Immunomediatory Molecule or CD278 or ICOS) - Drugs in Development, 2021 Summary Induc...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| ATP Binding Cassette Sub Family G Member 2 (Breast Cancer Resistance Protein or Mitoxantrone Resistance Associated Protein or Placenta Specific ATP Binding Cassette Transporter or Urate Exporter or CD338 or ABCG2) - Drugs in Development, 2021
ATP Binding Cassette Sub Family G Member 2 (Breast Cancer Resistance Protein or Mitoxantrone Resistance Associated Protein or Placenta Specific ATP Bi...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Lung Infections (Respiratory) - Drugs in Development, 2021
Lung Infections (Respiratory) - Drugs in Development, 2021 Summary Lung Infections (Respiratory) - Drugs in Development, 2021 provides an overview o...
Published: Apr-2021 | No. of Pages: 45
|
$ 2000 | |
| Chronic Thromboembolic Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021
Chronic Thromboembolic Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021 Summary Chronic Thromboembolic Pulmonary Hypertension (C...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) (Genetic Disorders) - Drugs in Development, 2021
Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) (Genetic Disorders) - Drugs in Development, 2021 Summary Netherton Syndrome (Trichorrhexi...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
| Anaplastic Thyroid Cancer (Oncology) - Drugs in Development, 2021
Anaplastic Thyroid Cancer (Oncology) - Drugs in Development, 2021 Summary Anaplastic Thyroid Cancer (Oncology) - Drugs in Development, 2021 provides...
Published: Apr-2021 | No. of Pages: 65
|
$ 2000 | |
| Cells Expressing Receptor Type Tyrosine Protein Kinase FLT3 (FMS Like Tyrosine Kinase 3 or FL Cytokine Receptor or Stem Cell Tyrosine Kinase 1 or Fetal Liver Kinase 2 or CD135 or FLT3 or EC 2.7.10.1) - Drugs in Development, 2021
Cells Expressing Receptor Type Tyrosine Protein Kinase FLT3 (FMS Like Tyrosine Kinase 3 or FL Cytokine Receptor or Stem Cell Tyrosine Kinase 1 or Feta...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Intermediate Conductance Calcium Activated Potassium Channel Protein 4 (KCa3.1 or Gardos Channel or KCNN4) - Drugs in Development, 2021
Intermediate Conductance Calcium Activated Potassium Channel Protein 4 (KCa3.1 or Gardos Channel or KCNN4) - Drugs in Development, 2021 Summary Inte...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 |